References

1. U.S. Department of health and human services. Centers for Disease Control and Prevention. Dengue and Dengue Hemorrhagic Fever: Information for Health Care Practitioners. Accessed 10 September 2019.


2. Hadinegoro SRS. The revised WHO dengue case classification: Does the system need to be modified? Paediatr Int Child Health. 2012 May;32 Suppl 1:33-8. PubMed | Google Scholar


3. Fagbami AH, Onoja AB. Dengue haemorrhagic fever: An emerging disease in Nigeria, West Africa. J Infect Public Health. 2018 Nov - Dec;11(6):757-762. PubMed | Google Scholar


4. Kalayanarooj S, Rothman AL, Srikiatkhachorn A. Case management of dengue: Lessons learned. J Infect Dis. 2017;215(Suppl 2):S79-88. PubMed | Google Scholar


5. Setrkraising K, Bongsebandhu-phubhakdi C, Voraphani N, Pancharoen C, Thisyakorn U, Thisyakorn C. D-dimer as an indicator of dengue severity. Asian Biomed. 2007;1(1):53-7. Google Scholar


6. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, García-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A. 2010;107(25):11531-6. PubMed | Google Scholar


7. Teixeira MG, Paixão ES, Costa M da CN, Cunha R V, Pamplona L, Dias JP et al. Arterial Hypertension and Skin Allergy Are Risk Factors for Progression from Dengue to Dengue Hemorrhagic Fever: A Case Control Study. PLoS Negl Trop Dis. 2015 May 21;9(5):e0003812. PubMed | Google Scholar


8. World Health Organization clinical management of patients with viral haemorrhagic fever: a pocket guide for front-line health workers: interim emergency guidance for country adaptation, February 2016. Google Scholar


9. Cavinato JL. World Health Organization guidelines for diagnosis, treatment, prevention and control. Accessed 26 August 2019.